New Teva CEO’s Initial Priorities Are Manufacturing, Copaxone, R&D
Executive Summary
Teva’s new CEO, Jeremy Levin, has been emphasizing manufacturing efficiency, global compliance and a more focused R&D structure in initial comments to Wall Street.